Presentation is loading. Please wait.

Presentation is loading. Please wait.

HIV Drugs Spreadsheet Documentation. General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2.

Published byHolly Nelson Modified over 9 years ago

Similar presentations

Presentation on theme: "HIV Drugs Spreadsheet Documentation. General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2."— Presentation transcript:

1 HIV Drugs Spreadsheet Documentation

2 General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2 MkNrOVE&usp=drive_web#gid=1 https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2 MkNrOVE&usp=drive_web#gid=1 Spreadsheet contains data regarding Summary of company rankings WHO groupings and country categorizations The burden of Malaria and the data of its drugs by countries The burden of TB and the data of its drugs by countries The burden of HIV and the data of its drugs by countries

3 Tab (1) Summary of Company Rankings List of pharmaceutical companies, their drugs and target diseases Ranking of the companies’ total impact scores: Total impact scores = Need (DALYs lost) * Access (Treatment coverage) * Efficacy Ranking of the companies break down by diseases Total DALYs alleviated in different diseases break down by WHO regions

4 Tab (5) HIV by Country General information Column A: List of countries Column B: Countries sorted by WHO regions Column C: population Column D: Geographical Region

5 Tab (5) HIV by Country General information (continued) Column E: WHO Group (“A” or “B”) Column F: DALYs lost to HIV by country (2010) Column G: DALYs lost by adults to HIV by country (2010, adults = 15+) Column H: DALYs lost by children to HIV by country (2010, children = <15)

6 Tab (5) HIV by Country Treatment Coverage Column I: Overall individuals receiving treatment by country (2010) Column J: Overall individuals needing treatment by country (2010) Column K: Treatment coverage for all individuals by country (Col I / Col J)

7 Tab (5) HIV by Country Treatment Coverage (continued) Column O: # of children receiving treatment by country (2010) Column P: # of children needing treatment by country (2010) Column Q: Treatment coverage children by country (Col O / Col P)

8 Tab (5) HIV by Country Treatment Coverage (continued) Column L: # of adults receiving treatment by country (Col I – Col O) Column M: # of adults needing treatment by country (Col J – Col P) Column N: Treatment coverage children by country (Col L / Col M)

9 Tab (5) HIV by Country WHO Group Column AF: WHO-designated group A countries Column AG: WHO-designated group B countries

10 Tab (5) HIV by Country Treatment Breakdown Summary Column AJ: Breakdown of treatment in WHO- designated group A countries Column AK: Breakdown of treatment in WHO- designated group B countries Example: of those receiving treatment, 92.76% are in group A countries. Of those, 93.13% are adults. Of those adults, 97.10% receive first- line treatment regimens

11 Tab (5) HIV by Country Treatment Efficacy Column AM: List of treatment regimens in WHO-designated group A countries: Treatment is first broken down into four quadrants: adult first-line, adult second-line, children first-line, and children second-line. The treatments for each quadrant are then listed

12 Tab (5) HIV by Country Treatment Efficacy (continued) Column AN: Proportional breakdown of percent in quadrant receiving treatment with the regimens listed in AM Column AO: Efficacy of each treatment regimen in that quadrant

13 Tab (5) HIV by Country Treatment Efficacy (continued) Columns AP-AR: The same procedure of regimen breakdown is repeated for WHO-designated group B countries

14 Tab (5) HIV by Country Impact Regimen impact is calculated by: Age-specific DALYs (Col G or H) * Age-specific treatment coverage (Col N or Q) * Percentage of cases receiving each particular type of treatment (Col AJ or AK) * Proportion of cases of receiving that type of treatment receiving each particular regimen (Column AN or AQ) * Efficacy of each regimen in that quadrant (Col AO or AR)

15 Tab (5) HIV by Country Impact (continued) Columns R-AC: Impact of each drug by country For every regimen of which each drug is a part, the drug receives (1/n) credit of the whole regimen, where n=number of drugs The total impact for each drug is the sum of its impact in each regimen Column AD: Total impact of HIV treatment by country

16 Tab (5) HIV by Country Company Ranking Column AT: List of originator companies for HIV treatment Column AU: Drugs credited to each company Column AV: Total impact of each company for HIV treatment

Download ppt "HIV Drugs Spreadsheet Documentation. General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2."

Similar presentations

Information regarding the effectiveness of each approach, such as the number of lives saved or the cost per life saved, would provide one.

Information regarding the effectiveness of each approach, such as the number of lives saved or the cost per life saved, would provide one.
TB/HIV Research Priorities: TB Preventive Therapy.

TB/HIV Research Priorities: TB Preventive Therapy.
TOWARDS UNIVERSAL ACCESS

TOWARDS UNIVERSAL ACCESS
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.

ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
Tim Crocker-Buqué 5 th Year – University of Nottingham Professor Harold Ellis Medical Student Prize for Surgery 9 th October 2009 What Effect can Surgeons.

Tim Crocker-Buqué 5 th Year – University of Nottingham Professor Harold Ellis Medical Student Prize for Surgery 9 th October 2009 What Effect can Surgeons.
Tuberculosis Drugs Spreadsheet Documentation. General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2.

Tuberculosis Drugs Spreadsheet Documentation. General Information Link to spreadsheet: c?key=0AuIkrFbUTuZldHJPZGtUNV9CSVFraEQ0TWZ2.
Percentile Rank Percentile rank (PR) refers to the position within a group that a person with a particular score is at. A person with percentile rank of.

Percentile Rank Percentile rank (PR) refers to the position within a group that a person with a particular score is at. A person with percentile rank of.
Measures of Impact Dublin June 2006. Measures of Impact You want to reduce deaths from road traffic accidents Most impact for least cost Cohort study.

Measures of Impact Dublin June Measures of Impact You want to reduce deaths from road traffic accidents Most impact for least cost Cohort study.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Blood and Airborne Pathogens HIV/AIDS/STDs/HepatitisTB/SARS/Influenza.

Blood and Airborne Pathogens HIV/AIDS/STDs/HepatitisTB/SARS/Influenza.
Malaria Drugs Spreadsheet Documentation. General Information Link to spreadsheet: https://docs.google.com/a/binghamton.edu/spreadsheet/cc c?key=0Ag8gS12PpxX2dF82NS1CLVhwd1RDSjhiMnFpd.

Malaria Drugs Spreadsheet Documentation. General Information Link to spreadsheet: c?key=0Ag8gS12PpxX2dF82NS1CLVhwd1RDSjhiMnFpd.
The Percent Proportion Percent of a number Find what percent 1 number is of another Find the base in percent problems.

The Percent Proportion Percent of a number Find what percent 1 number is of another Find the base in percent problems.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Overview of AIMSweb Reports

Overview of AIMSweb Reports
Frequency Table Frequency tables are an efficient method of displaying data The number of cases for each observed score are listed Scores that have 0 cases.

Frequency Table Frequency tables are an efficient method of displaying data The number of cases for each observed score are listed Scores that have 0 cases.
HEALTH AND NUTRITION IN THE CARIBBEAN BY M S. N. L EWIS.

HEALTH AND NUTRITION IN THE CARIBBEAN BY M S. N. L EWIS.
HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.

HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.

2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
The Health Impact of New Pharmaceutical Products in the Context of Health Impact Funds International Conference on Equity and Access to Medicines: Role.

The Health Impact of New Pharmaceutical Products in the Context of Health Impact Funds International Conference on Equity and Access to Medicines: Role.

Similar presentations

Ads by Google